These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Effect of thio-TEPA on the forelimb buds of the mouse embryo in vitro]. Yamamura H; Nishimura H; Okada T Kaibogaku Zasshi; 1966 Oct; 41(5):259-67. PubMed ID: 4959472 [No Abstract] [Full Text] [Related]
6. [Teratogenic effects of the workplace on pregnant women]. Pataki J Orv Hetil; 1990 Oct; 131(41):2288. PubMed ID: 2234924 [No Abstract] [Full Text] [Related]
7. Environmental hazards in the work setting: their effect on women of child-bearing age. Dye-White E AAOHN J; 1986 Feb; 34(2):76-8. PubMed ID: 3633193 [No Abstract] [Full Text] [Related]
8. [Adverse effect of thio tepa on the hemopoiesis and complications arising with it]. Andriukin AA; Vinogradova ON; Akhtomova LV Sov Med; 1968 Sep; 31(9):127-9. PubMed ID: 4989665 [No Abstract] [Full Text] [Related]
9. A methodology for studying the effect of industrial exposure on adverse pregnancy outcome. Cuckle H Prog Clin Biol Res; 1985; 163B():269-72. PubMed ID: 3983150 [No Abstract] [Full Text] [Related]
10. Reproductive hazards in the workplace. Karrh BW Del Med J; 1986 Mar; 58(3):203-4. PubMed ID: 3699204 [No Abstract] [Full Text] [Related]
11. [Effect of thio-TEPA and benzo-TEPA on the glycogen forming function of the liver in rabbits]. Zel'vin BM Vopr Onkol; 1967; 13(3):76-9. PubMed ID: 4972958 [No Abstract] [Full Text] [Related]
12. Potentiating effects of caffeine on teratogenicity of alkylating agents in mice. Fujii T; Nakatsuka T Teratology; 1983 Aug; 28(1):29-33. PubMed ID: 6415842 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation of occupational teratogenic hazards based on data from the Hungarian Case-Control Surveillance System for Congenital Anomalies]. Király J; Czeizel E Orv Hetil; 1986 Aug; 127(31):1871-6. PubMed ID: 3737192 [No Abstract] [Full Text] [Related]
14. [A case of agranulocytosis following use of thio-TEPA]. Vagina OG; Vasiliev AK Pediatr Akus Ginekol; 1972 Oct; 5():61-2. PubMed ID: 4633307 [No Abstract] [Full Text] [Related]
15. [Depression of bone marrow after intravesical use of Thio-tepa]. Malling N Ugeskr Laeger; 1980 Sep; 142(40):2630-1. PubMed ID: 6777928 [No Abstract] [Full Text] [Related]
16. [Teratogenic effect of thiophosphamide on mice of different genotypes]. Korogodina IuV; Kaurov BA Biull Eksp Biol Med; 1984 Mar; 97(3):331-2. PubMed ID: 6423011 [TBL] [Abstract][Full Text] [Related]
17. [Behavior of adult mice of various strains after exposure of thiophosphamide during organogenesis]. Lil'p IG; Bizikoeva FZ; Poletaeva II; Ivanov VI Genetika; 1995 Jan; 31(1):101-10. PubMed ID: 7896120 [TBL] [Abstract][Full Text] [Related]
18. [Agranulocytic reaction associated with thio-tepa therapy]. Kirko EI; Veshler VM; Tarasenko OP Klin Med (Mosk); 1971 May; 49(5):131-2. PubMed ID: 5003827 [No Abstract] [Full Text] [Related]
19. [The state of hemopoiesis in the regional perfusion of malignant tumors of the extremities with sarcolysin, thio-TEPA and cyclophosphane]. Levin AO; Babinina VF Vopr Onkol; 1967; 13(2):48-54. PubMed ID: 4971006 [No Abstract] [Full Text] [Related]
20. [Treatment of disseminated breast cancer with triethylen-thiophosphoramide (thio-tepa)]. Madrigal Alonso PL; Perez Gomez FJ Acta Oncol (Madr); 1969; 8(2):135-42. PubMed ID: 4988905 [No Abstract] [Full Text] [Related] [Next] [New Search]